Bank of America’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Buy
503,640
+364,763
+263% +$3.95M ﹤0.01% 3363
2025
Q4
$1.78M Sell
138,877
-206,413
-60% -$2.55M ﹤0.01% 4159
2025
Q3
$3.86M Buy
345,290
+59,082
+21% +$570K ﹤0.01% 4255
2025
Q2
$2.84M Buy
286,208
+251,702
+729% +$2.46M ﹤0.01% 4439
2025
Q1
$324K Sell
34,506
-33,489
-49% -$352K ﹤0.01% 5900
2024
Q4
$623K Sell
67,995
-1,968
-3% -$14.5K ﹤0.01% 5381
2024
Q3
$544K Sell
69,963
-13,860
-17% -$100K ﹤0.01% 5430
2024
Q2
$507K Sell
83,823
-38,922
-32% -$240K ﹤0.01% 5332
2024
Q1
$721K Sell
122,745
-21,077
-15% -$125K ﹤0.01% 5129
2023
Q4
$1.13M Sell
143,822
-82,546
-36% -$573K ﹤0.01% 4889
2023
Q3
$1.65M Buy
226,368
+129,992
+135% +$1.08M ﹤0.01% 4440
2023
Q2
$1.01M Buy
96,376
+9,997
+12% +$96.2K ﹤0.01% 4774
2023
Q1
$893K Buy
86,379
+34,258
+66% +$438K ﹤0.01% 4971
2022
Q4
$718K Sell
52,121
-2,417
-4% -$33.6K ﹤0.01% 5123
2022
Q3
$1.11M Sell
54,538
-15,376
-22% -$338K ﹤0.01% 4806
2022
Q2
$1.35M Buy
69,914
+35,088
+101% +$719K ﹤0.01% 4636
2022
Q1
$750K Sell
34,826
-31,388
-47% -$712K ﹤0.01% 5494
2021
Q4
$1.83M Buy
66,214
+15,018
+29% +$414K ﹤0.01% 4651
2021
Q3
$1.33M Buy
51,196
+13,294
+35% +$355K ﹤0.01% 4810
2021
Q2
$1.03M Sell
37,902
-49,108
-56% -$1.2M ﹤0.01% 4883
2021
Q1
$2.04M Buy
87,010
+45,486
+110% +$919K ﹤0.01% 4249
2020
Q4
$637K Sell
41,524
-10,118
-20% -$128K ﹤0.01% 4838
2020
Q3
$623K Sell
51,642
-7,969
-13% -$75.6K ﹤0.01% 4551
2020
Q2
$606K Buy
59,611
+21,043
+55% +$217K ﹤0.01% 4476
2020
Q1
$402K Sell
38,568
-27,213
-41% -$342K ﹤0.01% 4658
2019
Q4
$1.05M Buy
65,781
+9,675
+17% +$148K ﹤0.01% 4468
2019
Q3
$1.03M Buy
56,106
+12,569
+29% +$246K ﹤0.01% 4519
2019
Q2
$857K Sell
43,537
-7,643
-15% -$156K ﹤0.01% 4681
2019
Q1
$1.17M Sell
51,180
-35,246
-41% -$765K ﹤0.01% 4400
2018
Q4
$1.74M Buy
86,426
+103
+0.1% +$2.13K ﹤0.01% 3974
2018
Q3
$1.88M Buy
86,323
+57,132
+196% +$1.27M ﹤0.01% 4027
2018
Q2
$649K Buy
29,191
+3,344
+13% +$68.3K ﹤0.01% 4746
2018
Q1
$446K Sell
25,847
-49,439
-66% -$825K ﹤0.01% 4898
2017
Q4
$1.25M Sell
75,286
-43,449
-37% -$741K ﹤0.01% 4333
2017
Q3
$2.03M Sell
118,735
-64,180
-35% -$1.08M ﹤0.01% 3963
2017
Q2
$2.97M Buy
182,915
+16,360
+10% +$259K ﹤0.01% 3526
2017
Q1
$2.89M Buy
166,555
+142,076
+580% +$2.38M ﹤0.01% 3542
2016
Q4
$413K Buy
24,479
+23,205
+1,821% +$387K ﹤0.01% 4940
2016
Q3
$22K Sell
1,274
-114,737
-99% -$1.86M ﹤0.01% 6091
2016
Q2
$1.67M Sell
116,011
-5,793
-5% -$72.4K ﹤0.01% 3780
2016
Q1
$1.5M Buy
121,804
+6,561
+6% +$72.5K ﹤0.01% 3811
2015
Q4
$1.4M Buy
115,243
+82,254
+249% +$1.01M ﹤0.01% 4105
2015
Q3
$435K Buy
32,989
+1,213
+4% +$18.3K ﹤0.01% 4890
2015
Q2
$521K Buy
31,776
+23,567
+287% +$391K ﹤0.01% 4665
2015
Q1
$146K Sell
8,209
-14,659
-64% -$272K ﹤0.01% 5117
2014
Q4
$435K Buy
22,868
+10,663
+87% +$181K ﹤0.01% 4738
2014
Q3
$167K Sell
12,205
-5,545
-31% -$79.1K ﹤0.01% 5550
2014
Q2
$290K Buy
17,750
+812
+5% +$11.8K ﹤0.01% 5179
2014
Q1
$267K Sell
16,938
-2,183
-11% -$35.6K ﹤0.01% 5181
2013
Q4
$328K Buy
19,121
+4,519
+31% +$69.5K ﹤0.01% 5146
2013
Q3
$193K Sell
14,602
-9,613
-40% -$113K ﹤0.01% 5480
2013
Q2
$273K Buy
+24,215
New +$258K ﹤0.01% 5319

Other funds holding ANGO

Bank of America's ANGO Position: Q1 2026 in Review

Bank of America increased its AngioDynamics (ANGO) stake by 263% in Q1 2026, buying an estimated $3.95M and bringing the position to 503,640 shares worth $5.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3363.

Bank of America first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Bank of America held 503,640 shares of AngioDynamics worth $5.73M as of Q1 2026.
  • Bank of America bought 364,763 AngioDynamics shares in Q1 2026, an estimated $3.95M.
  • AngioDynamics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3363 holding.
  • Bank of America first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.